Dec 19, 2009 | Posted by: roboblogger
Full story: Customer Interaction Solutions![]()
December 18, 2009 Flamel Technologies trading at $7.67 on a volume of 2,300 shares Flamel Technologies Announces the Initiation of a Phase 2a Clinical Trial of Flamel's IFN-Alpha-2b XL in Patients with Chronic Hepatitis C Virus Infection LYON, France, Dec 18, 2009 -- Flamel Technologies today announced the initiation of a Phase 2a clinical trial of ...
Post
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
|
|
Sat | diane77 | 1 |
|
|
Fri | Blessed | 87 |
|
|
Mar 19 | goldenhinde | 1 |
|
|
Mar 18 | teretweter | 1 |
|
|
Mar 17 | juliet4584 | 1 |
|
|
Mar 17 | noteasyoffended | 98 |
|
|
Mar 8 | Nic | 18 |